Emulsion tech for eye drug delivery wins award
A drug delivery system that promises to improve the treatment of a range of eye diseases, in development at French pharmaceutical company Novagali Pharma, has won a Kaye Innovation Award.
A drug delivery system that promises to improve the treatment of a range of eye diseases, in development at French pharmaceutical company Novagali Pharma, has won a Kaye Innovation Award.
Living Cell Technologies (LCT) are set to put a major dent in the market for diabetic treatments after they announced the retrieval of live, insulin-producing cells, from a patient, in a transplant that did not require the use of immunosuppressive drugs.
BioProgress has allowed the exclusive partnership with US drugmaker Wyeth on over-the-counter applications of its SWOLLO oral dosage form technology to lapse, reports Phil Taylor.
New anti-breast cancer drugs could be developed after latest research suggested that Omega-3, a fatty acid found in oily fish, could be combined with an anaesthetic to reduce the ability of breast cancer cells to develop into malignant tumours.
Caliper Life Sciences launches a high-volume liquid handling system, which enables independent control of fluid delivery to individual microplate wells, becoming only one of a handful of liquid handlers currently on the market that can independently...
Lanxess is to transform its fine chemicals business out into a legally-discrete subsidiary as part of a programme to increase its competitiveness in the market for pharmaceutical and agricultural chemicals, reports Phil Taylor.
Researchers at the Georgia Institute of Technology in the US have developed a device that has the potential to reduce the time needed to analyse proteins, shorten development times for new drugs and bring down the overall cost of protein analysis...
Surface Logix has commenced Phase I clinical trials for a novel PDE-5 inhibitor for the treatment of cardiovascular diseases, including endothelial dysfunction and erectile dysfunction.
Taiwanese company Panion & BF Biotech has been awarded a US patent on high-grade ferric citrate that could be used as an active pharmaceutical ingredient for the treatment of iron deficiency diseases, renal failure and elevated blood phosphate,...